Measuring Pelvic Floor Disorder Symptoms Using Patient-Reported Instruments: Proceedings of the Consensus Meeting of the Pelvic Floor Consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction

Affiliations

¹ Section Colorectal Surgery, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
² Department of Urology, California School of Health Sciences, Los Angeles, California.
³ Department of Colorectal Surgery, McGill University, Montreal, Canada.
⁴ Department of Colorectal Surgery, University of Colorado, Denver, Colorado.
⁵ Division of Colon and Rectal Surgery, University of California Irvine, Irvine, California.
⁶ Department of Female Pelvic Floor Medicine and Reconstruction, University of Colorado, Denver, Colorado.
⁷ Department of Urology, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
⁸ Department of Colorectal Surgery, University of Illinois, Chicago, Illinois.
⁹ Division of Gastroenterology, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
¹⁰ Department of Colorectal Surgery, Pelvic Floor Center, University of Minnesota, Minneapolis, Minnesota.
¹¹ Department of Female Pelvic Floor Medicine and Reconstruction Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
¹² Department of Urology, Center for Men's Health, University of California Irvine, Irvine, California.
¹³ Department of Colorectal Surgery, Cleveland Clinic Hospitals, Cleveland, Ohio.

Free article

Liliana G Bordeianou et al. Female Pelvic Med Reconstr Surg. 2020 Jan/Feb.

Free article

. 2020 Jan/Feb;26(1):1-15.

doi: 10.1097/SPV.0000000000000817.

¹ Section Colorectal Surgery, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
² Department of Urology, California School of Health Sciences, Los Angeles, California.
³ Department of Colorectal Surgery, McGill University, Montreal, Canada.
⁴ Department of Colorectal Surgery, University of Colorado, Denver, Colorado.
⁵ Division of Colon and Rectal Surgery, University of California Irvine, Irvine, California.
⁶ Department of Female Pelvic Floor Medicine and Reconstruction, University of Colorado, Denver, Colorado.
⁷ Department of Urology, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
⁸ Department of Colorectal Surgery, University of Illinois, Chicago, Illinois.
⁹ Division of Gastroenterology, Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
¹⁰ Department of Colorectal Surgery, Pelvic Floor Center, University of Minnesota, Minneapolis, Minnesota.
¹¹ Department of Female Pelvic Floor Medicine and Reconstruction Center for Pelvic Floor Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
¹² Department of Urology, Center for Men's Health, University of California Irvine, Irvine, California.
¹³ Department of Colorectal Surgery, Cleveland Clinic Hospitals, Cleveland, Ohio.

No abstract available

References

1. McLeod LD, Coon CD, Martin SA, et al. Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res. 2011;11:163–169.
1. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1948;1:634–656.
1. Fayers P, Machin D. Quality of Life: The Assessment, Analysis and Interpretation of Patient-Reported Outcomes. 2nd ed. Chichester: John Wiley & Sons; 2007.
1. Rockwood TH, Church JM, Fleshman JW, et al. Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum. 1999;42:1525–1532.
1. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79.